97 results
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
and prospective investors. The engagement agreement does not give rise to any commitment by the placement agent to purchase any of our securities … by this prospectus may be sold:
through agents;
to or through one or more underwriters on a firm commitment or agency basis;
through put or call
20-F/A
2023 FY
EX-2.1
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
to nullify registered share capital that has not yet been allocated, provided that there is no commitment, including a conditioned commitment
F-3
BLRX
Bioline Rx Ltd
29 Dec 23
Shelf registration (foreign)
4:15pm
one or more underwriters on a firm commitment or agency basis;
through put or call option transactions relating to the securities;
to or through … underwriters on a firm commitment or best efforts basis;
exchange distributions and/or secondary distributions;
ordinary brokerage transactions
6-K
EX-99
BLRX
Bioline Rx Ltd
12 Oct 23
BioLineRx Announces Closing of Exclusive License Agreement to Motixafortide
7:14am
the upfront payment and equity investment demonstrates a clear commitment to the motixafortide programs in stem cell mobilization and pancreatic cancer in Asia
424B5
BLRX
Bioline Rx Ltd
20 Sep 22
Prospectus supplement for primary offering
4:30pm
and negotiations between us, the placement agent and prospective investors. The engagement agreement does not give rise to any commitment by the placement agent … being offered by this prospectus may be sold:
through agents;
to or through one or more underwriters on a firm commitment or agency basis;
through
6-K
EX-99
tuiqmw6n
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
0bz syjvz36x5m5x
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
opyne 2bxr5p
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-10.1
qgggqs2
3 Sep 21
Current report (foreign)
4:30pm
424B5
5s1utd2svdqyiq8zka61
3 Sep 21
Prospectus supplement for primary offering
4:29pm
6-K
EX-99.1
ov6zwlpnw3j9r
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99.2
qcjk873ah
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
yp6bqak ncw3kph
21 Jan 21
Prospectus supplement for primary offering
4:31pm
FWP
hhcxnpka y8
19 Jan 21
Free writing prospectus
9:46pm
FWP
g1awu8p 8sd5x
19 Jan 21
Free writing prospectus
5:01pm
424B5
jxzbhj1ddak7u0
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
fb3zyax2b
31 Dec 20
Shelf registration (foreign)
4:37pm
6-K
EX-10.1
g4qflr
25 Sep 20
Current report (foreign)
4:33pm
424B5
o3vswp
3 Jun 20
Prospectus supplement for primary offering
8:33am